ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,498 | -47.8% | 10,340 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $221,276 | -47.1% | 10,340 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $418,150 | -13.1% | 10,340 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $481,017 | -10.3% | 10,340 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $536,336 | +3.5% | 10,340 | -5.6% | 0.01% | +25.0% |
| Q2 2022 | $518,032 | -33.6% | 10,959 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $780,062 | +53.0% | 10,959 | +60.7% | 0.01% | +25.0% |
| Q4 2021 | $510,000 | +31.6% | 6,820 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $387,444 | +6.1% | 6,820 | -17.8% | 0.00% | +33.3% |
| Q2 2021 | $365,019 | -10.8% | 8,294 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $409,060 | +17.1% | 8,294 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $349,177 | -8.0% | 8,294 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $379,699 | -8.8% | 8,294 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $416,442 | -2.4% | 8,294 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $426,560 | -9.1% | 8,294 | +9.2% | 0.01% | +20.0% |
| Q4 2019 | $469,404 | +2.8% | 7,598 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $456,488 | -28.8% | 7,598 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $641,119 | -11.7% | 7,598 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $725,761 | +34.9% | 7,598 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $538,166 | -17.1% | 7,598 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $649,325 | -26.3% | 7,598 | 0.0% | 0.01% | -30.0% |
| Q2 2018 | $881,000 | +43.3% | 7,598 | 0.0% | 0.01% | +42.9% |
| Q1 2018 | $615,000 | +37.9% | 7,598 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $446,000 | – | 7,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
| Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
| Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
| Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
| Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
| ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
| Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
| Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |